These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2129379)

  • 41. Blood rheology in acute myocardial infarction: effects of high-dose i.v. streptokinase compared to placebo.
    Arntz HR; Perchalla G; Roll D; Heitz J; Schäfer JH; Schröder R
    Eur Heart J; 1992 Feb; 13(2):275-80. PubMed ID: 1555628
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intravenous recombinant tissue-type plasminogen activator in acute myocardial infarction.
    Gao R; Chen J; Kou W; Yao K; Xu Y; Lu Z; Yu Q; Tao P; Ma J; Zhu J
    Chin Med Sci J; 1991 Sep; 6(3):132-5. PubMed ID: 1793874
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pitfalls in the economic evaluation of thrombolysis in myocardial infarction. The impact of national differences in the cost of thrombolytics and of differences in the efficacy across patient subgroups.
    Lorenzoni R; Pagano D; Mazzotta G; Rosen SD; Fattore G; De Caterina R; Gensini G
    Eur Heart J; 1998 Oct; 19(10):1518-24. PubMed ID: 9820990
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction.
    Mark DB; Hlatky MA; Califf RM; Naylor CD; Lee KL; Armstrong PW; Barbash G; White H; Simoons ML; Nelson CL
    N Engl J Med; 1995 May; 332(21):1418-24. PubMed ID: 7723799
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dose-ranging study with a new two-chain rt-PA in patients with acute myocardial infarction: a multicenter trial.
    DeWood MA; Kurnik PB; Jolly MK; Jain AC; Khaja F; Gorfinkel HJ; Morris DL; Satler L; LittleJohn J
    Clin Cardiol; 1993 Apr; 16(4):302-10. PubMed ID: 8458110
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Thrombolytic drugs in acute myocardial infarct].
    Ambrosioni E; Degli Esposti D
    Cardiologia; 1991 Dec; 36(12 Suppl 1):395-402. PubMed ID: 1841796
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Streptokinase and tissue plasminogen activator in acute myocardial infarction.
    Brewer CC; Markis JE
    Heart Lung; 1986 Nov; 15(6):552-8. PubMed ID: 3095269
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Thrombolysis in acute myocardial infarction. Streptokinase or r-TPA?].
    Silva LA; Ribeiro E; Carneiro RC; Kaissar S; Reis Filho A; Torossian SP; Tavares JR; Buffolo E; Amino JG; Duprat Filho R
    Arq Bras Cardiol; 1990 Jul; 55(1):13-7. PubMed ID: 2127353
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [t-PA in thrombolytic therapy of acute myocardial infarct].
    Rutsch W; Schmutzler H
    Herz; 1994 Dec; 19(6):336-52. PubMed ID: 7843690
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Tissue-type plasminogen activator (t-PA): comments on results of the GISSI-2 study].
    Turazza FM
    Medicina (Firenze); 1990; 10(2):193-4. PubMed ID: 2125681
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Thrombolysis in acute myocardial infarction: analysis of studies comparing accelerated t-PA and streptokinase.
    Smith BJ
    J Accid Emerg Med; 1999 Nov; 16(6):407-11. PubMed ID: 10572811
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [A trial of the use of a new thrombolytic preparation--recombinant tissue-type plasminogen activator--in myocardial infarct patients].
    Plotnikov AN; Staroverov II; Tagieva IA; Dorogun BN; Pomerantsev EV; Dobrovol'skiĭ AB; Ruda MIa
    Kardiologiia; 1993; 33(3):32-6. PubMed ID: 8377337
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Increase in thrombin generation after coronary thrombolysis with rt-PA or streptokinase with simultaneous heparin versus heparin alone.
    Réganon E; Ferrando F; Vila V; Villa P; Martínez-Sales V; Fayos L; Ruano M; Aznar J
    Haemostasis; 1998; 28(2):99-105. PubMed ID: 10087435
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [rt-PA in acute myocardial infarct, randomized studies in Europe and the USA].
    von Essen R
    Z Kardiol; 1986; 75 Suppl 5():101-6. PubMed ID: 3103344
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Incomplete recanalization as an important determinant of Thrombolysis in Myocardial Infarction (TIMI) grade 2 flow after thrombolytic therapy for acute myocardial infarction. TEAM Investigators. Thrombolytic Trial of Eminase in Acute Myocardial Infarction.
    Zahger D; Karagounis LA; Cercek B; Anderson JL; Sorensen S; Moreno F; Shah PK
    Am J Cardiol; 1995 Oct; 76(11):749-52. PubMed ID: 7572648
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The absence of a procoagulant effect after TNK-t-PA: a comparison with streptokinase and rt-PA].
    De Marco E; Andreotti F; van de Greef W; Quaranta G; Biasucci LM; Kol A; Maseri A; Rebuzzi AG
    Cardiologia; 1998 Nov; 43(11):1209-13. PubMed ID: 9922587
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Use of fibrinolytics in the treatment of acute myocardial infarction in Denmark. A questionnaire study].
    Nielsen JD; Stoltenberg M; Siemsen M; Juul A; Pedersen F; Madsen JK
    Ugeskr Laeger; 1990 Aug; 152(33):2368-70. PubMed ID: 2120830
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The rt-PA versus streptokinase controversy--III.
    Sherry S; Marder VJ
    J Am Coll Cardiol; 1992 Apr; 19(5):1119-20. PubMed ID: 1552104
    [No Abstract]   [Full Text] [Related]  

  • 59. Rescue thrombolysis: alteplase as adjuvant treatment after streptokinase in acute myocardial infarction.
    Mounsey JP; Skinner JS; Hawkins T; MacDermott AF; Furniss SS; Adams PC; Kesteven PJ; Reid DS
    Br Heart J; 1995 Oct; 74(4):348-53. PubMed ID: 7488444
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The rt-PA versus streptokinase controversy--IV.
    Swan HJ
    J Am Coll Cardiol; 1992 Apr; 19(5):1120. PubMed ID: 1552105
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.